Taiwan Biomaterial Co., Ltd. (TPEX:6649)
45.10
-0.10 (-0.22%)
At close: Mar 27, 2026
Taiwan Biomaterial Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 258.41 | 205.34 | 171.68 | 183.15 | 91.65 |
Short-Term Investments | 97.5 | 107.5 | 132.5 | 149.5 | 61 |
Cash & Short-Term Investments | 355.91 | 312.84 | 304.18 | 332.65 | 152.65 |
Cash Growth | 13.76% | 2.85% | -8.56% | 117.92% | -26.86% |
Accounts Receivable | 36.05 | 11.92 | 14.39 | 16.04 | 2.4 |
Other Receivables | 0.91 | 0.6 | 0.5 | 0.25 | 0.01 |
Receivables | 36.96 | 12.52 | 14.89 | 16.29 | 2.41 |
Inventory | 59.35 | 40.59 | 48.43 | 17.8 | 9.98 |
Prepaid Expenses | 16.67 | 5.35 | 4.04 | 7.75 | 11.1 |
Total Current Assets | 468.88 | 371.3 | 371.54 | 374.49 | 176.14 |
Property, Plant & Equipment | 271.54 | 325.37 | 336.39 | 351.49 | 363.35 |
Long-Term Investments | 0.17 | 0.13 | 0.09 | 0.06 | 0.04 |
Other Intangible Assets | 1.73 | 1.28 | 1.58 | 2.37 | 1.98 |
Other Long-Term Assets | 47.63 | 6.47 | 6.68 | 6.91 | 12.28 |
Total Assets | 789.95 | 704.56 | 716.28 | 735.31 | 553.79 |
Accounts Payable | 20.25 | 4.7 | 8.25 | 3.62 | 6.65 |
Accrued Expenses | - | 12.3 | 14.02 | 11.92 | 12.6 |
Current Portion of Leases | 4.46 | 4.4 | 5.18 | 7.22 | 6.88 |
Current Income Taxes Payable | - | - | 1.1 | - | - |
Current Unearned Revenue | 0.76 | 0.47 | - | - | - |
Other Current Liabilities | 29.52 | 3.93 | 4.33 | 4.49 | 37.37 |
Total Current Liabilities | 54.99 | 25.81 | 32.87 | 27.25 | 63.5 |
Long-Term Leases | 48.13 | 52.59 | 55.52 | 61.29 | 67.04 |
Other Long-Term Liabilities | 1.74 | - | - | 0.35 | 0.35 |
Total Liabilities | 104.86 | 78.4 | 88.38 | 88.89 | 130.89 |
Common Stock | 420 | 420 | 420 | 420 | 330 |
Additional Paid-In Capital | 192.67 | 192.67 | 192.67 | 192.67 | 265.98 |
Retained Earnings | 72.42 | 13.49 | 15.23 | 33.76 | -174.11 |
Comprehensive Income & Other | - | - | - | - | 1.03 |
Shareholders' Equity | 685.09 | 626.16 | 627.89 | 646.42 | 422.89 |
Total Liabilities & Equity | 789.95 | 704.56 | 716.28 | 735.31 | 553.79 |
Total Debt | 52.59 | 56.99 | 60.7 | 68.51 | 73.92 |
Net Cash (Debt) | 303.32 | 255.85 | 243.48 | 264.14 | 78.73 |
Net Cash Growth | 18.55% | 5.08% | -7.82% | 235.51% | -40.61% |
Net Cash Per Share | 7.21 | 6.09 | 5.80 | 6.46 | 2.39 |
Filing Date Shares Outstanding | 42.36 | 42 | 42 | 42 | 33 |
Total Common Shares Outstanding | 42.36 | 42 | 42 | 42 | 33 |
Working Capital | 413.89 | 345.5 | 338.67 | 347.24 | 112.64 |
Book Value Per Share | 16.17 | 14.91 | 14.95 | 15.39 | 12.81 |
Tangible Book Value | 683.36 | 624.88 | 626.31 | 644.06 | 420.92 |
Tangible Book Value Per Share | 16.13 | 14.88 | 14.91 | 15.33 | 12.76 |
Buildings | - | 267.85 | 267.85 | 267.85 | - |
Machinery | - | 53.51 | 49.68 | 50.71 | 48.87 |
Construction In Progress | - | - | - | - | 267.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.